Dr. Di Prospero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Johnson and Johnson
920 Route 202 South
Raritan, NJ 08869Phone+1 908-927-7881
Education & Training
- NIH Clinical Center2006
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2003
- MedStar Health/Georgetown University HospitalInternship, Internal Medicine, 1999 - 2000
- Rutgers Robert Wood Johnson Medical SchoolClass of 1999
Certifications & Licensure
- DC State Medical License 2002 - 2018
- VA State Medical License 2000 - 2018
- Diplomate, American Board of Internal Medicine
Publications & Presentations
PubMed
- 34 citationsEfficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ ‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐r...Nicholas A. Di Prospero, Jaqueline Yee, Mary Ellen Frustaci, Mahesh N. Samtani, Maria Alba
Clinical Obesity. 2021-01-21 - 88 citationsMechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition.Debapriya Basu, Lesley-Ann Huggins, Diego Scerbo, Joseph C. Obunike, Adam E. Mullick
Arteriosclerosis, Thrombosis, and Vascular Biology. 2018-09-01 - 6 citationsPharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes.William V. Tamborlane, David Polidori, Domenick Argenti, Nicholas A. Di Prospero
Pediatric Diabetes. 2018-06-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: